| John Sessions, DPM, PHD | |
|
4305 River Rd N, Keizer, OR 97303-5506 | |
| (503) 363-0763 | |
| (503) 363-8154 |
| Full Name | John Sessions |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 7 Years |
| Location | 4305 River Rd N, Keizer, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750817714 | NPI | - | NPPES |
| 500782216 | Medicaid | OR |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Silverton Medical Center | Silverton, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Willamette Foot Center Inc | 9436575396 | 2 |
News Archive
The new study presented at the 2017 American Thoracic Society International Conference has found that about 22.1%, approximately one in four adults, failed to respond to antibiotics for community-acquired pneumonia (CAP) treatment.
Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.
VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.
If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of-big, both proportionately and epidemiologically.
› Verified 8 days ago
| Provider Name | Willamette Foot Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730797762 PECOS PAC ID: 9436575396 Enrollment ID: O20200821002968 |
News Archive
The new study presented at the 2017 American Thoracic Society International Conference has found that about 22.1%, approximately one in four adults, failed to respond to antibiotics for community-acquired pneumonia (CAP) treatment.
Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.
VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.
If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of-big, both proportionately and epidemiologically.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Sessions, DPM, PHD 4305 River Rd N, Keizer, OR 97303-5506 Ph: (503) 363-0763 | John Sessions, DPM, PHD 4305 River Rd N, Keizer, OR 97303-5506 Ph: (503) 363-0763 |
News Archive
The new study presented at the 2017 American Thoracic Society International Conference has found that about 22.1%, approximately one in four adults, failed to respond to antibiotics for community-acquired pneumonia (CAP) treatment.
Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.
VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.
If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of-big, both proportionately and epidemiologically.
› Verified 8 days ago
Robert Stevens, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4305 River Rd N, Keizer, OR 97303 Phone: 503-363-0763 Fax: 503-363-8154 | |
Dr. Earl Dean Mcnabb, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3625 River Rd N, #275, Keizer, OR 97303 Phone: 503-390-0959 Fax: 503-390-1184 | |
Pacific Nw Foot And Ankle Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3625 River Rd N Ste 275, Keizer, OR 97303 Phone: 503-390-0959 Fax: 877-878-1984 | |
Willamette Foot Center Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 4305 River Rd N, Keizer, OR 97303 Phone: 503-363-0763 Fax: 503-363-8154 | |
Dr. Debra Kaye Lynch, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4905 River Road N, Keizer, OR 97303 Phone: 503-304-5030 Fax: 503-606-2944 |